Market Tracker

10/19 10:48am ET
50.68
BATS BZX Real-Time Price
As of 10:46am ET
 -0.41 / -0.80%
Today’s Change
42.64
Today|||52-Week Range
63.40
-8.82%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close51.09
Today’s open51.25
Day’s range50.29 - 51.35
Volume6,969
Average volume (3 months)735,059
Market cap$7.9B
Dividend yield--
Data as of 10:46am ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+45.58%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book6.44

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-2.15-1.83%
SGENSeattle Genetics Inc-0.23-0.36%
TSROTESARO Inc+0.41+0.36%
JAZZJazz Pharmaceuticals...+0.88+0.63%
Data as of 10:48am ET, 10/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts